世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

粘膜下注入剤の世界市場調査レポート2023年版


Global Submucosal Injection Agent Market Research Report 2023

粘膜下注入剤の世界市場は、2022年に9743万米ドル、2029年には1億6351万米ドルに達すると予測され、予測期間2023-2029年に7.67%のCAGRを記録しています。市場規模を推定する際には、COVID-19とオランダ・ウクライ... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年4月4日 US$2,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

粘膜下注入剤の世界市場は、2022年に9743万米ドル、2029年には1億6351万米ドルに達すると予測され、予測期間2023-2029年に7.67%のCAGRを記録しています。市場規模を推定する際には、COVID-19とオランダ・ウクライナ戦争の影響を考慮しました。

レポートスコープ
本レポートは、粘膜下注入剤の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、粘膜下注入剤に関するビジネス上の意思決定に役立てることを目的としています。

粘膜下注射剤の市場規模、推計、予測は、2022年を基準年とみなし、2018年から2022年までの期間の履歴と予測データを、販売量(K Unit)と収益($ million)で提供しています。本レポートでは、世界の粘膜下注入剤市場を包括的に区分しています。タイプ別、用途別、プレイヤー別の製品に関する地域別市場規模も掲載しています。
市場をより深く理解するために、競争環境、主要な競合他社、それぞれの市場ランクのプロフィールを掲載しています。また、技術動向や新製品開発についても考察しています。
本レポートは、企業別、タイプ別、用途別、地域別に、市場全体とサブセグメントにまたがる収益、販売量、平均価格に関する情報を提供し、本市場の粘膜下注入剤メーカー、新規参入企業、産業チェーン関連企業のお役に立つでしょう。

会社別
精華楽
オベスコ内視鏡
GIサプライ
コスモファーマシューティカルズ
ボストンサイエンティフィック
ザ・スタンダード
マイクロテック内視鏡
エンドクロットプラス

タイプ別セグメント
シリンジタイプ
アンプルタイプ

アプリケーション別セグメント
ホスピタルズ
外来手術センター
スペシャリティクリニック

地域別消費量
北アメリカ
U.S.
カナダ
メキシコ

アジア太平洋
中国
日本
韓国
インド
東南アジア
オーストラリア
その他のアジア太平洋地域

ヨーロッパ
ドイツ
連邦王国
フランス
ロシア
イタリア
スペイン
その他のヨーロッパ

ラテンアメリカ
ブラジル
アルゼンチン
コロンビア
ラテンアメリカの残りの地域

ページTOPに戻る


目次

1 Submucosal Injection Agent Market Overview 1
1.1 Product Definition 1
1.2 Submucosal Injection Agent by Type 1
1.2.1 Global Submucosal Injection Agent Market Value Comparison by Type (2023-2029) 2
1.2.2 Syringe Type 3
1.2.3 Ampoule Type 3
1.3 Submucosal Injection Agent by Application 4
1.4 Global Submucosal Injection Agent Market Size Estimates and Forecasts 6
1.4.1 Global Submucosal Injection Agent Revenue 2018-2029 6
1.4.2 Global Submucosal Injection Agent Sales 2018-2029 8
1.5 Assumptions and Limitations 8
2 Submucosal Injection Agent Market Competition by Manufacturers 10
2.1 Global Submucosal Injection Agent Sales Market Share by Manufacturers (2020-2023) 10
2.2 Global Submucosal Injection Agent Revenue Market Share by Manufacturers (2020-2023) 12
2.3 Global Submucosal Injection Agent Average Price by Manufacturers (2020-2023) 14
2.4 Global Key Players of Submucosal Injection Agent, Industry Ranking, 2021 VS 2022 VS 2023 14
2.5 Global Key Manufacturers of Submucosal Injection Agent, Manufacturing Sites & Headquarters 15
2.6 Global Key Manufacturers of Submucosal Injection Agent, Product Type 15
2.7 Global Submucosal Injection Agent Market Competitive Situation and Trends 16
2.7.1 Global Submucosal Injection Agent Market Concentration Rate 16
2.7.2 The Global 3 and 5 Largest Submucosal Injection Agent Players Market Share by Revenue 17
2.7.3 Global Submucosal Injection Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 18
3 Global Submucosal Injection Agent Market Scenario by Region 19
3.1 Global Submucosal Injection Agent Market Size by Region: 2018 Versus 2022 Versus 2029 19
3.2 Global Submucosal Injection Agent Sales by Region: 2018-2029 20
3.2.1 Global Submucosal Injection Agent Sales by Region: 2018-2023 20
3.2.2 Global Submucosal Injection Agent Sales by Region: 2024-2029 20
3.3 Global Submucosal Injection Agent Revenue by Region: 2018-2029 21
3.3.1 Global Submucosal Injection Agent Revenue by Region: 2018-2023 21
3.3.2 Global Submucosal Injection Agent Revenue by Region: 2024-2029 22
3.4 North America Submucosal Injection Agent Market Facts & Figures by Country 22
3.4.1 North America Submucosal Injection Agent Sales by Country (2018-2029) 22
3.4.2 North America Submucosal Injection Agent Revenue by Country (2018-2029) 23
3.4.3 United States 25
3.4.4 Canada 25
3.4.5 Mexico 26
3.5 Europe Submucosal Injection Agent Market Facts & Figures by Country 26
3.5.1 Europe Submucosal Injection Agent Sales by Country (2018-2029) 26
3.5.2 Europe Submucosal Injection Agent Revenue by Country (2018-2029) 27
3.5.3 Germany 29
3.5.4 France 29
3.5.5 U.K. 30
3.5.6 Italy 30
3.5.7 Russia 31
3.5.8 Spain 31
3.6 Asia Pacific Submucosal Injection Agent Market Facts & Figures by Region 32
3.6.1 Asia Pacific Submucosal Injection Agent Sales by Region (2018-2029) 32
3.6.2 Asia Pacific Submucosal Injection Agent Revenue by Region (2018-2029) 33
3.6.3 China 35
3.6.4 Japan 35
3.6.5 South Korea 36
3.6.6 India 36
3.6.7 Australia 37
3.6.8 Southeast Asia 37
3.7 Latin America Submucosal Injection Agent Market Facts & Figures by Country 38
3.7.1 Latin America Submucosal Injection Agent Sales by Country (2018-2029) 38
3.7.2 Latin America Submucosal Injection Agent Revenue by Country 39
3.7.3 Brazil 40
3.7.4 Argentina 41
3.7.5 Colombia 41
3.8 Middle East and Africa Submucosal Injection Agent Market Facts & Figures by Country 42
3.8.1 Middle East and Africa Submucosal Injection Agent Sales by Country (2018-2029) 42
3.8.2 Middle East and Africa Submucosal Injection Agent Revenue by Country 43
3.8.3 Middle East 44
3.8.4 Africa 45
4 Segment by Type 46
4.1 Global Submucosal Injection Agent Sales by Type (2018-2029) 46
4.1.1 Global Submucosal Injection Agent Sales by Type (2018-2023) 46
4.1.2 Global Submucosal Injection Agent Sales by Type (2024-2029) 46
4.1.3 Global Submucosal Injection Agent Sales Market Share by Type (2018-2029) 46
4.2 Global Submucosal Injection Agent Revenue by Type (2018-2029) 47
4.2.1 Global Submucosal Injection Agent Revenue by Type (2018-2023) 47
4.2.2 Global Submucosal Injection Agent Revenue by Type (2024-2029) 47
4.2.3 Global Submucosal Injection Agent Revenue Market Share by Type (2018-2029) 48
4.3 Global Submucosal Injection Agent Price by Type (2018-2029) 49
5 Segment by Application 50
5.1 Global Submucosal Injection Agent Sales by Application (2018-2029) 50
5.1.1 Global Submucosal Injection Agent Sales by Application (2018-2023) 50
5.1.2 Global Submucosal Injection Agent Sales by Application (2024-2029) 50
5.1.3 Global Submucosal Injection Agent Sales Market Share by Application (2018-2029) 50
5.2 Global Submucosal Injection Agent Revenue by Application (2018-2029) 51
5.2.1 Global Submucosal Injection Agent Revenue by Application (2018-2023) 51
5.2.2 Global Submucosal Injection Agent Revenue by Application (2024-2029) 52
5.2.3 Global Submucosal Injection Agent Revenue Market Share by Application (2018-2029) 52
5.3 Global Submucosal Injection Agent Price by Application (2018-2029) 53
6 Key Companies Profiled 54
6.1 Seikagaku 54
6.1.1 Seikagaku Corporation Information 54
6.1.2 Seikagaku Introduction and Business Overview 54
6.1.3 Seikagaku Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 54
6.1.4 Seikagaku Submucosal Injection Agent Products Offered 55
6.2 Ovesco Endoscopy 55
6.2.1 Ovesco Endoscopy Corporation Information 55
6.2.2 Ovesco Endoscopy Introduction and Business Overview 56
6.2.3 Ovesco Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 56
6.2.4 Ovesco Endoscopy Submucosal Injection Agent Products Offered 56
6.3 GI Supply 57
6.3.1 GI Supply Corporation Information 57
6.3.2 GI Supply Introduction and Business Overview 58
6.3.3 GI Supply Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 58
6.3.4 GI Supply Submucosal Injection Agent Products Offered 58
6.4 Cosmo Pharmaceuticals 59
6.4.1 Cosmo Pharmaceuticals Corporation Information 59
6.4.2 Cosmo Pharmaceuticals Introduction and Business Overview 59
6.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 60
6.4.4 Cosmo Pharmaceuticals Submucosal Injection Agent Products Offered 60
6.5 Boston Scientific 61
6.5.1 Boston Scientific Corporation Information 61
6.5.2 Boston Scientific Introduction and Business Overview 61
6.5.3 Boston Scientific Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 61
6.5.4 Boston Scientific Submucosal Injection Agent Products Offered 62
6.6 The Standard 62
6.6.1 The Standard Corporation Information 62
6.6.2 The Standard Introduction and Business Overview 63
6.6.3 The Standard Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 63
6.6.4 The Standard Submucosal Injection Agent Products Offered 63
6.7 Micro-Tech Endoscopy 64
6.7.1 Micro-Tech Endoscopy Corporation Information 64
6.7.2 Micro-Tech Endoscopy Introduction and Business Overview 64
6.7.3 Micro-Tech Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 65
6.7.4 Micro-Tech Endoscopy Submucosal Injection Agent Products Offered 65
6.8 EndoClot Plus 66
6.8.1 EndoClot Plus Corporation Information 66
6.8.2 EndoClot Plus Introduction and Business Overview 66
6.8.3 EndoClot Plus Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 67
6.8.4 EndoClot Plus Submucosal Injection Agent Products Offered 67
7 Industry Chain and Sales Channels Analysis 68
7.1 Submucosal Injection Agent Industry Chain Analysis 68
7.2 Submucosal Injection Agent Key Raw Materials 68
7.2.1 Key Raw Materials 68
7.2.2 Raw Materials Key Suppliers 70
7.2.3 Raw Materials 70
7.2.4 Labor Cost 71
7.2.5 Manufacturing Expenses 71
7.3 Submucosal Injection Agent Sales and Marketing 71
7.3.1 Submucosal Injection Agent Distributors 71
7.4 Submucosal Injection Agent Customers 72
8 Submucosal Injection Agent Market Dynamics 74
8.1 Submucosal Injection Agent Industry Trends 74
8.2 Submucosal Injection Agent Market Drivers 74
8.3 Submucosal Injection Agent Market Challenges 75
9 Research Findings and Conclusion 76
10 Methodology and Data Source 77
10.1 Methodology/Research Approach 77
10.1.1 Research Programs/Design 77
10.1.2 Market Size Estimation 77
10.1.3 Market Breakdown and Data Triangulation 79
10.2 Data Source 80
10.2.1 Secondary Sources 80
10.2.2 Primary Sources 81
10.3 Author List 83
10.4 Disclaimer 85

 

ページTOPに戻る


 

Summary

The global Submucosal Injection Agent market was valued at US$ 97.43 million in 2022 and is anticipated to reach US$ 163.51 million by 2029, witnessing a CAGR of 7.67% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Submucosal Injection Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Submucosal Injection Agent.

The Submucosal Injection Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2022. This report segments the global Submucosal Injection Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Submucosal Injection Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company
Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus

Segment by Type
Syringe Type
Ampoule Type

Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Consumption by Region
North America
U.S.
Canada
Mexico

Asia-Pacific
China
Japan
Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific

Europe
Germany
UK
France
Russia
Italy
Spain
Rest of Europe

Latin America
Brazil
Argentina
Colombia
Rest of Latin America



ページTOPに戻る


Table of Contents

1 Submucosal Injection Agent Market Overview 1
1.1 Product Definition 1
1.2 Submucosal Injection Agent by Type 1
1.2.1 Global Submucosal Injection Agent Market Value Comparison by Type (2023-2029) 2
1.2.2 Syringe Type 3
1.2.3 Ampoule Type 3
1.3 Submucosal Injection Agent by Application 4
1.4 Global Submucosal Injection Agent Market Size Estimates and Forecasts 6
1.4.1 Global Submucosal Injection Agent Revenue 2018-2029 6
1.4.2 Global Submucosal Injection Agent Sales 2018-2029 8
1.5 Assumptions and Limitations 8
2 Submucosal Injection Agent Market Competition by Manufacturers 10
2.1 Global Submucosal Injection Agent Sales Market Share by Manufacturers (2020-2023) 10
2.2 Global Submucosal Injection Agent Revenue Market Share by Manufacturers (2020-2023) 12
2.3 Global Submucosal Injection Agent Average Price by Manufacturers (2020-2023) 14
2.4 Global Key Players of Submucosal Injection Agent, Industry Ranking, 2021 VS 2022 VS 2023 14
2.5 Global Key Manufacturers of Submucosal Injection Agent, Manufacturing Sites & Headquarters 15
2.6 Global Key Manufacturers of Submucosal Injection Agent, Product Type 15
2.7 Global Submucosal Injection Agent Market Competitive Situation and Trends 16
2.7.1 Global Submucosal Injection Agent Market Concentration Rate 16
2.7.2 The Global 3 and 5 Largest Submucosal Injection Agent Players Market Share by Revenue 17
2.7.3 Global Submucosal Injection Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 18
3 Global Submucosal Injection Agent Market Scenario by Region 19
3.1 Global Submucosal Injection Agent Market Size by Region: 2018 Versus 2022 Versus 2029 19
3.2 Global Submucosal Injection Agent Sales by Region: 2018-2029 20
3.2.1 Global Submucosal Injection Agent Sales by Region: 2018-2023 20
3.2.2 Global Submucosal Injection Agent Sales by Region: 2024-2029 20
3.3 Global Submucosal Injection Agent Revenue by Region: 2018-2029 21
3.3.1 Global Submucosal Injection Agent Revenue by Region: 2018-2023 21
3.3.2 Global Submucosal Injection Agent Revenue by Region: 2024-2029 22
3.4 North America Submucosal Injection Agent Market Facts & Figures by Country 22
3.4.1 North America Submucosal Injection Agent Sales by Country (2018-2029) 22
3.4.2 North America Submucosal Injection Agent Revenue by Country (2018-2029) 23
3.4.3 United States 25
3.4.4 Canada 25
3.4.5 Mexico 26
3.5 Europe Submucosal Injection Agent Market Facts & Figures by Country 26
3.5.1 Europe Submucosal Injection Agent Sales by Country (2018-2029) 26
3.5.2 Europe Submucosal Injection Agent Revenue by Country (2018-2029) 27
3.5.3 Germany 29
3.5.4 France 29
3.5.5 U.K. 30
3.5.6 Italy 30
3.5.7 Russia 31
3.5.8 Spain 31
3.6 Asia Pacific Submucosal Injection Agent Market Facts & Figures by Region 32
3.6.1 Asia Pacific Submucosal Injection Agent Sales by Region (2018-2029) 32
3.6.2 Asia Pacific Submucosal Injection Agent Revenue by Region (2018-2029) 33
3.6.3 China 35
3.6.4 Japan 35
3.6.5 South Korea 36
3.6.6 India 36
3.6.7 Australia 37
3.6.8 Southeast Asia 37
3.7 Latin America Submucosal Injection Agent Market Facts & Figures by Country 38
3.7.1 Latin America Submucosal Injection Agent Sales by Country (2018-2029) 38
3.7.2 Latin America Submucosal Injection Agent Revenue by Country 39
3.7.3 Brazil 40
3.7.4 Argentina 41
3.7.5 Colombia 41
3.8 Middle East and Africa Submucosal Injection Agent Market Facts & Figures by Country 42
3.8.1 Middle East and Africa Submucosal Injection Agent Sales by Country (2018-2029) 42
3.8.2 Middle East and Africa Submucosal Injection Agent Revenue by Country 43
3.8.3 Middle East 44
3.8.4 Africa 45
4 Segment by Type 46
4.1 Global Submucosal Injection Agent Sales by Type (2018-2029) 46
4.1.1 Global Submucosal Injection Agent Sales by Type (2018-2023) 46
4.1.2 Global Submucosal Injection Agent Sales by Type (2024-2029) 46
4.1.3 Global Submucosal Injection Agent Sales Market Share by Type (2018-2029) 46
4.2 Global Submucosal Injection Agent Revenue by Type (2018-2029) 47
4.2.1 Global Submucosal Injection Agent Revenue by Type (2018-2023) 47
4.2.2 Global Submucosal Injection Agent Revenue by Type (2024-2029) 47
4.2.3 Global Submucosal Injection Agent Revenue Market Share by Type (2018-2029) 48
4.3 Global Submucosal Injection Agent Price by Type (2018-2029) 49
5 Segment by Application 50
5.1 Global Submucosal Injection Agent Sales by Application (2018-2029) 50
5.1.1 Global Submucosal Injection Agent Sales by Application (2018-2023) 50
5.1.2 Global Submucosal Injection Agent Sales by Application (2024-2029) 50
5.1.3 Global Submucosal Injection Agent Sales Market Share by Application (2018-2029) 50
5.2 Global Submucosal Injection Agent Revenue by Application (2018-2029) 51
5.2.1 Global Submucosal Injection Agent Revenue by Application (2018-2023) 51
5.2.2 Global Submucosal Injection Agent Revenue by Application (2024-2029) 52
5.2.3 Global Submucosal Injection Agent Revenue Market Share by Application (2018-2029) 52
5.3 Global Submucosal Injection Agent Price by Application (2018-2029) 53
6 Key Companies Profiled 54
6.1 Seikagaku 54
6.1.1 Seikagaku Corporation Information 54
6.1.2 Seikagaku Introduction and Business Overview 54
6.1.3 Seikagaku Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 54
6.1.4 Seikagaku Submucosal Injection Agent Products Offered 55
6.2 Ovesco Endoscopy 55
6.2.1 Ovesco Endoscopy Corporation Information 55
6.2.2 Ovesco Endoscopy Introduction and Business Overview 56
6.2.3 Ovesco Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 56
6.2.4 Ovesco Endoscopy Submucosal Injection Agent Products Offered 56
6.3 GI Supply 57
6.3.1 GI Supply Corporation Information 57
6.3.2 GI Supply Introduction and Business Overview 58
6.3.3 GI Supply Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 58
6.3.4 GI Supply Submucosal Injection Agent Products Offered 58
6.4 Cosmo Pharmaceuticals 59
6.4.1 Cosmo Pharmaceuticals Corporation Information 59
6.4.2 Cosmo Pharmaceuticals Introduction and Business Overview 59
6.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 60
6.4.4 Cosmo Pharmaceuticals Submucosal Injection Agent Products Offered 60
6.5 Boston Scientific 61
6.5.1 Boston Scientific Corporation Information 61
6.5.2 Boston Scientific Introduction and Business Overview 61
6.5.3 Boston Scientific Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 61
6.5.4 Boston Scientific Submucosal Injection Agent Products Offered 62
6.6 The Standard 62
6.6.1 The Standard Corporation Information 62
6.6.2 The Standard Introduction and Business Overview 63
6.6.3 The Standard Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 63
6.6.4 The Standard Submucosal Injection Agent Products Offered 63
6.7 Micro-Tech Endoscopy 64
6.7.1 Micro-Tech Endoscopy Corporation Information 64
6.7.2 Micro-Tech Endoscopy Introduction and Business Overview 64
6.7.3 Micro-Tech Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 65
6.7.4 Micro-Tech Endoscopy Submucosal Injection Agent Products Offered 65
6.8 EndoClot Plus 66
6.8.1 EndoClot Plus Corporation Information 66
6.8.2 EndoClot Plus Introduction and Business Overview 66
6.8.3 EndoClot Plus Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 67
6.8.4 EndoClot Plus Submucosal Injection Agent Products Offered 67
7 Industry Chain and Sales Channels Analysis 68
7.1 Submucosal Injection Agent Industry Chain Analysis 68
7.2 Submucosal Injection Agent Key Raw Materials 68
7.2.1 Key Raw Materials 68
7.2.2 Raw Materials Key Suppliers 70
7.2.3 Raw Materials 70
7.2.4 Labor Cost 71
7.2.5 Manufacturing Expenses 71
7.3 Submucosal Injection Agent Sales and Marketing 71
7.3.1 Submucosal Injection Agent Distributors 71
7.4 Submucosal Injection Agent Customers 72
8 Submucosal Injection Agent Market Dynamics 74
8.1 Submucosal Injection Agent Industry Trends 74
8.2 Submucosal Injection Agent Market Drivers 74
8.3 Submucosal Injection Agent Market Challenges 75
9 Research Findings and Conclusion 76
10 Methodology and Data Source 77
10.1 Methodology/Research Approach 77
10.1.1 Research Programs/Design 77
10.1.2 Market Size Estimation 77
10.1.3 Market Breakdown and Data Triangulation 79
10.2 Data Source 80
10.2.1 Secondary Sources 80
10.2.2 Primary Sources 81
10.3 Author List 83
10.4 Disclaimer 85

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る